Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | 7819995354 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| NT-0796 | C23H27N3O4 | 2272917-13-0 | Details |
| PRX-07034 hydrochloride | C21H28ClN3O4S.ClH | 903580-39-2 | Details |
| GGACK (hydrochloride) | Details |
| 4-Nitrophenyl dodecanoate | C18H27NO4 | 1956-11-2 | Details |
| 11β-HSD1-IN-12 | C19H27ClN2O3S | 872506-67-7 | Details |
| Calcifediol monohydrate | C27H46O3 | 63283-36-3 | Details |
| Uridine-5'-monophosphate (sodium salt hydrate) | C9H13N2Na2O10P | 681435-27-8 | Details |
| Dihydrosinapyl alcohol | C11H16O4 | 20736-25-8 | Details |
| SXC 2023 | C13H15NO4S | 1695562-36-7 | Details |
| (R)-Naroparcil | C19H17NO4S2 | 252647-51-1 | Details |
| Eclitasertib | C19H18N6O3 | 2125450-76-0 | Details |
| Docosane | C22H46 | 629-97-0 | Details |
| MCTR3 | C25H37NO5S | 1784701-63-8 | Details |
| 17-trifluoromethylphenyl trinor Prostaglandin F2α methyl ester | C25H33F3O5 | 195503-20-9 | Details |
| PACMA 31 | C21H22N2O6S | 1401089-31-3 | Details |
| Kansuinine A | C37H46O15 | 57701-86-7 | Details |
| Rel-TREM2 agonist-2 | C24H23ClFN5O | 2738485-99-7 | Details |
| Saccharocarcin A | C67H101NO20 | 158475-32-2 | Details |
| Methyl 3,4-Dihydroxyphenylacetate | C9H10O4 | 25379-88-8 | Details |
| DiR iodide | C63H101IN2 | Details |
| 6'-hydroxydihydrocinchonidine | C19H24N2O2 | 5962-19-6 | Details |
| PF-07258669 | C25H27FN6O2 | 2755890-53-8 | Details |
| 1,3,6,8-Tetrahydroxynaphthalene | C10H8O4 | 18512-30-6 | Details |
| 1,3-BUTANEDIOL | C4H10O2 | 107-88-0 | Details |
| Gantofiban | C21H29N5O6 | 183547-57-1 | Details |
| LMPTP INHIBITOR 1 hydrochloride | C28H37ClN4O | 2310135-38-5 | Details |
| IMB-XMA0038 | C11H10N4O6 | 921812-26-2 | Details |
| GPX4-IN-6 | C18H17BrFNO5 | 2922824-07-3 | Details |
| Pinocembrin 7-O-[3''-O-galloyl-4'',6''-hexahydroxydiphenoyl]-β-D-glucoside | C42H32O21 | 205370-59-8 | Details |
| NF-κΒ activator 1 | C16H11FN2O2S | 2387524-59-4 | Details |
| Secoisolariciresinol diglucoside | C32H46O16 | 158932-33-3 | Details |
| 3-(3,6-dichloro-9H-carbazol-9-yl)propanoic acid | C15H11Cl2NO2 | 300816-42-6 | Details |
| 9(S)-HOTrE | C18H30O3 | 89886-42-0 | Details |
| C2-8 | C19H14Br2N2O3S | 300670-16-0 | Details |
| ABC34 | C31H33N5O6 | 1831135-56-8 | Details |
| EM-12 | C13H12N2O3 | 26581-81-7 | Details |
| PKI 14-22 amide, myristoylated Acetate | Details |
| 5-Aminothalidomide | C13H11N3O4 | 191732-76-0 | Details |
| Aurora kinase inhibitor-2 | C23H20N4O3 | 331770-21-9 | Details |
| 17-hydroxy Venturicidin A | C41H67NO12 | 113204-43-6 | Details |
| GSK046 | C23H27FN2O4 | 2474876-09-8 | Details |
| Trastuzumab deruxtecan | 1826843-81-5 | Details |
| Scandoside | C16H22O11 | 18842-99-4 | Details |
| 1,4-DPCA | C13H8N2O3 | 331830-20-7 | Details |
| 1-Palmitoyl Lysophosphatidic Acid (sodium salt) | C19H37Na2O7P | 17618-08-5 | Details |
| Pinolenic Acid ethyl ester | C20H34O2 | 493015-74-0 | Details |
| Arecoline | C8H13NO2 | 63-75-2 | Details |
| BMS-488043 | C22H22N4O5 | 452296-83-2 | Details |
| Vantictumab | 1345009-45-1 | Details |
| AT-121 | C24H38N4O3S | 2099681-31-7 | Details |
| Dihydro Montelukast | C35H38ClNO3S | 142147-67-9 | Details |
| CAY10770 | C14H20N4O2 | 2428734-45-4 | Details |
| PD 198306 | C18H16F3IN2O2 | 212631-61-3 | Details |
| (R)-Monepantel | C20H13F6N3O2S | 887148-70-1 | Details |
| GSK-3β inhibitor 10 | C12H12N2O3S | 1198098-03-1 | Details |
| CYM2503 | C45H55N5O7 | 1308833-36-4 | Details |
| SDZ 220-040 ammonium | Details |
| Azomethine-H monosodium | C17H14NNaO8S2 | 5941-07-1 | Details |
| ANT3310 | C6H10FN2NaO5S | 2410688-61-6 | Details |
| SI 60 | C18H17F6OSSb | 133152-67-7 | Details |
| AVG-233 | C26H22ClN5O3 | 2151937-80-1 | Details |
| Shepherdin 79-87 acetate | Details |
| Rhod-2 (sodium salt) | C40H39N4Na3O11 | Details |
| Tazomeline | C14H23N3S2 | 131987-54-7 | Details |
| MBP MAPK Substrate acetate | Details |
| CYP2A6-IN-1 | C12H16F3N | 912291-11-3 | Details |
| Kukoamine B mesylate | C28H42N4O6.CH4O3S | 1375179-86-4 | Details |
| α-Conotoxin GI acetate | Details |
| Caroverine hydrochloride | C22H27N3O2 | 55750-05-5 | Details |
| Ibritumomab | Details |
| sbp-7455 | C16H17F3N4O2 | 1884222-74-5 | Details |
| CA77.1 | C16H12ClN3O | 2412270-22-3 | Details |
| PD-1/PD-L1-IN-9 | C22H24N2O2 | 2628506-54-5 | Details |
| GV-150013X | C33H34N4O3 | 151386-96-8 | Details |
| DPTN dihydrochloride | C22H18N4OS.2ClH | 325767-87-1 | Details |
| CIA-1 (Free base) | C17H19N3O2S | 452087-38-6 | Details |
| SGK1-IN-4 | C23H21ClFN5O4S | 1628048-93-0 | Details |
| Venadaparib | C23H23FN4O2 | 1681017-83-3 | Details |
| Qa-1b&B2M&Qdm (AMAPRTLLL) Monomer Protein, Mouse, MHC (His & Avi) | Details |
| AMC-01 | C27H27BrN2O6 | 1047978-71-1 | Details |
| Protonstatin-1 | C8H5NO2S2 | 521972-99-6 | Details |
| 4-[(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]benzoic acid | C11H7NO4S | 199167-79-8 | Details |
| PCSK9 Protein, Human, Recombinant (D374Y & V474I & G670E, His) | Details |
| 25-Desacetyl Rifampicin | C41H56N4O11 | 16783-99-6 | Details |
| Vanillic acid glucoside | C14H18O9 | 32142-31-7 | Details |
| (±)5(6)-EpETE methyl ester | C21H32O3 | 127716-49-8 | Details |
| 1,2,3-Trilinoelaidoyl-rac-glycerol | C57H98O6 | 5188-25-0 | Details |
| SphK1&2-IN-1 | C14H14N2O3S | 1415662-57-5 | Details |
| VT104 | C25H19F3N2O | 2417718-25-1 | Details |
| Pomisartan 2HCl | Details |
| 13(S)-HpOTrE(γ) | C18H30O4 | 121107-97-9 | Details |
| 11β-HSD1 inibitor 19 | C19H16ClF4N3O2S | 946400-19-7 | Details |
| Nexinhib20 | C15H16N4O3 | 331949-35-0 | Details |
| Semax acetate(80714-61-0 free base) | C37H51N9O10S.C2H4O2 | 2828433-33-4 | Details |
| Ciamexon | C11H13N3O | 75985-31-8 | Details |
| 2,3-dihydro-1H-indene-5-sulfonamide | C9H11NO2S | 35203-93-1 | Details |
| 10'-Desmethoxystreptonigrin | C24H20N4O7 | 136803-89-9 | Details |
| Solpecainol | C18H23NO3 | 155321-96-3 | Details |
| ATG7-IN-1 | C17H19FN6O5S2 | 2226229-87-2 | Details |
| Arofylline | C14H13ClN4O2 | 136145-07-8 | Details |
| Product Total： Product Page： | ||||
| 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 | ||||